Related Experiment Videos
Carcinogens, drugs, and cytochromes P-450
The New England Journal of Medicine
|July 14, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification.
Xenobiotica; the fate of foreign compounds in biological systems·2004
Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.
Drug metabolism and disposition: the biological fate of chemicals·2001
An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys.
Xenobiotica; the fate of foreign compounds in biological systems·2000
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
Cordyceps sinensis and Sonodynamic Therapy in Non-Small Cell Lung Cancer: Pharmacological Basis, Therapeutic Potential, and Future Directions.
International journal of nanomedicine·2026
Shikonin in Hepatocellular Carcinoma: Bridging Metabolic Disruption and Immunomodulation.
Journal of hepatocellular carcinoma·2026
Multidimensional viscoelastic mechanical indexes for assessing chemotherapeutic drug efficacy and chemoresistance.
British journal of pharmacology·2026
EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Boswellic Acid and Its Derivatives For the Treatment of Colon Cancer: A Review.
Mini reviews in medicinal chemistry·2026